Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use vials, Rx ...

FDA Recall #D-0478-2024 — Class III — April 10, 2024

Recall #D-0478-2024 Date: April 10, 2024 Classification: Class III Status: Ongoing

Product Description

Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use vials, Rx only, Imprimis NJOF, LLC 1705 Route 46 West, Unit 6B, Ledgewood, NJ, 07852, NDC 71384-640-01

Reason for Recall

Out of specification for assay

Recalling Firm

Imprimis NJOF, LLC — Ledgewood, NJ

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

15,414 units

Distribution

Nationwide within the United States

Code Information

Lot #: 23JUL028, Exp. Date 8/1/2024; 23AUG053, Exp. Date 8/30/2024

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated